Maternal use of valproate during pregnancy has been associated with an increased risk of neurodevelopmental disorders in children. Although most studies of other antiseizure medications have not shown ...
Novel therapy for epilepsy and bipolar disorders received FDA approval in September CHICAGO – October 23, 2025 — OWP Pharmaceuticals, a privately held, commercial-stage neuroscience specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback